Skip to main content
. Author manuscript; available in PMC: 2010 May 26.
Published in final edited form as: Leuk Lymphoma. 2010 Jan;51(1):73–78. doi: 10.3109/10428190903318329

Table I.

Treatment groups.

5-AC Cytarabine
Group 1 37.5 mg/m2/day IV over 20–30 min daily ×7 100 mg/m2/day continuous intravenous infusion (CIV) ×7 days
Group 2 75 mg/m2/day IV over 20–30 min daily ×7 100 mg/m2/day continuous intravenous infusion (CIV) ×7 days
Group 3 37.5 mg/m2/day IV over 20–30 min daily ×7 1g/m2/day CIV days 1–4 (age <65 years) or days 1–3 (age ≥65 years)
Group 4 75 mg/m2/day IV over 20–30 min daily ×7 1g/m2/day CIV days 1–4 (age <65 years) or days 1–3 (age ≥65 years)